However, BCP inhibited non-small cell lung cancer (NSCLC) growth via dysregulating the antioxidant enzymes (SOD, CAT and GPx) and ROS, and increasing apoptotic factors (cleaved caspase-3 and Bax) in these cells [20]. Here, CASP3 is linked to non-small cell lung carcinoma.